BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 890959)

  • 1. Serum pyruvate kinase in carriers of Duochenne muscular dystrophy.
    Yamuna S; Valmikinathan K; Burt D; Emery AE
    Clin Chim Acta; 1977 Aug; 79(1):277-9. PubMed ID: 890959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.
    Savonitto C; Bonadonna G; Bongiovanni LG; Duso E; De Grandis D
    Ital J Neurol Sci; 1983 Dec; 4(4):417-22. PubMed ID: 6674240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
    J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the serum biochemistry in carrier detection of Duchenne muscular dystrophy].
    Xie B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):165-8, 189. PubMed ID: 1889329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pyruvate kinase in carriers of Duchenne muscular dystrophy.
    Hardy MF; Gardner-Medwin D; Pennington RJ
    J Neurol Sci; 1977 May; 32(1):137-9. PubMed ID: 864489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy.
    Aston JP; Kingston HM; Ramasamy I; Walters EG; Stansbie D
    J Neurol Sci; 1984 Sep; 65(3):307-14. PubMed ID: 6491692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies.
    Zatz M; Shapiro LJ; Campion DS; Oda E; Kaback MM
    J Neurol Sci; 1978 May; 36(3):349-62. PubMed ID: 681967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
    Rapaport D; Colletto GM; Zatz M
    Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne muscular dystrophy in a girl with a 45,X/46,XX/47,XXX chromosome constitution.
    Bortolini ER; da Silva DM; Chequer RS; Vianna-Morgante AM; Zatz M
    Am J Med Genet; 1986 Oct; 25(2):239-43. PubMed ID: 3777022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duchenne muscular dystrophy: comparison among different racial groups.
    Bortolini ER; Zatz M
    Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: pyruvate kinase isoenzymes and creatine phosphokinase in serum and blood cells.
    Smith I; Thomson WH
    Clin Chim Acta; 1977 Aug; 78(3):439-51. PubMed ID: 884869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.